Send feedback

CDKN2A p.Pro114Ser

c.340C>T · rs104894104 · VCV1405931

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely pathogenic
0.8619 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 8.48e-05%, nfe)
Missense predictors
3/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
familial melanoma

Computational evidence

Protein change
AlphaMissense0.8619likely pathogenic
REVEL0.759pathogenic-leaning
SaProtLLR -13.60damaging
⇒ AlphaMissense, REVEL and SaProt all call this damaging.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP 12GERP 2, phastCons 1
Regional constrainto/e 1.13unconstrained · MANE · 6,595 bp · p 0.04 · regional, not allelic
Overall
CADD27.4PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 8.48e-05% European (non-Finnish) · 1/1,179,714 alleles
Overall 6.22e-05% 1/1,607,566 alleles · very rare exomes 0/1,455,220 · genomes 1/152,346 · joint denominator

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CDKN2A
Protein
p.Pro114Ser
Coding
c.340C>T
MANE Select
NM_000077
dbSNP
rs104894104
Type
single nucleotide variant
Location
chr9:21971019 (GRCh38)
Gene constraint
LOEUF 0.791 · pLI 0.62 · ClinGen HI 3/3 (gnomAD)
Structure
AlphaFold pLDDT 77.02 · 5 PDB
Residue 114
an α-helix; a UniProt-annotated variant site (in non-small cell lung carcinoma); a UniProt-annotated variant site (found in some patients with melanoma; loss of cdk4 binding); the 'disordered' region
Full CDKN2A gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

familial melanoma — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Familial melanoma (Orphanet):

Inheritance
Autosomal dominant, Multigenic/multifactorial
Onset
Adult
Prevalence
1-9 / 100 000 (Europe)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cdkn2a-p-pro114ser (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown